Oncomed Pharmaceuticals News Headlines (NASDAQ:OMED) Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Oncomed Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.89 0.00 (0.00 %) (As of 01/22/2020 01:09 PM ET) Add Compare Today's Range$0.89Now: $0.89▼$0.8950-Day Range$0.89MA: $0.89▼$0.8952-Week Range$0.55Now: $0.89▼$3.35VolumeN/AAverage Volume768,904 shsMarket Capitalization$34.43 millionP/E RatioN/ADividend YieldN/ABeta1.86 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Headlines Oncomed Pharmaceuticals (NASDAQ OMED) News Headlines Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance DateHeadlineMereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumabwww.prnewswire.com - January 13 at 1:00 PMMereo BioPharma's (MREO) CEO Denise Scots-Knight on 2019 Interim Financial Results and Corporate Update Conference Callseekingalpha.com - September 17 at 5:35 PMMereo BioPharma Loss Narrows On Gain From OncoMed Buy And Expenseswww.morningstar.co.uk - September 17 at 9:28 AMCancer Stem Cells Market: Comprehensive study explores Huge Growth in Futurewww.marketwatch.com - August 21 at 10:13 AMCancer Stem Cell Market: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2023www.marketwatch.com - August 13 at 9:49 PMViaCyte to Expand Board of Directors with Two New Appointmentswww.marketwatch.com - July 24 at 11:59 AMCancer Stem Cell: The Next Booming Market in the World| MacroGenics, OncoMed Pharmaceuticals, STEMCELL Technologieswww.marketwatch.com - May 16 at 8:51 AMAmunix Expands Executive Team with Appointment of Dr. Mika Derynck as CMO, Dr. Darcy Mootz as CBO, and Yvonne Li as SVP of Financewww.globenewswire.com - May 14 at 11:41 AMCiti Appointed as Depositary Bank for Mereo BioPharma’s ADR Programmewww.marketwatch.com - April 24 at 11:16 AMMereo BioPharma Completes Merger With OncoMed Pharmaceuticalswww.morningstar.co.uk - April 23 at 11:02 AMMereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, Inc.finance.yahoo.com - April 23 at 11:02 AMOncoMed Shareholders Approve All-Share Merger With Mereo BioPharmawww.lse.co.uk - April 18 at 11:37 AMMereo BioPharma Scures Further Acceptances From OncoMed Shareholderswww.morningstar.co.uk - March 15 at 4:19 PMOncoMed declares one-time contractual right dividend; shares up 7% premarketseekingalpha.com - March 15 at 11:55 AMOncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rightsfinance.yahoo.com - March 15 at 11:55 AMOncoMed Announces Fourth Quarter and Full Year 2018 Financial Resultsfinance.yahoo.com - March 7 at 4:19 PMMereo BioPharma Withdraws US Listing Application On OncoMed Deal (ALLIPO)www.morningstar.co.uk - February 22 at 12:37 PMMereo BioPharma Founding Director Departs Before OncoMed Combinationwww.morningstar.co.uk - February 11 at 8:45 AMMereo Publicly Files Registration Statement on Form F-4 with U.S. Securities and Exchange Commission - GlobeNewswirewww.globenewswire.com - January 25 at 10:37 AMGossamer Bio Announces Appointment of Jakob Dupont, M.D. as Chief Medical Officerwww.businesswire.com - December 17 at 3:59 PM This page was last updated on 1/22/2020 by MarketBeat.com StaffFeatured Article: What is a Buy-Side Analyst?